CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
40.72
+0.34 (0.83%)
At close: Dec 20, 2024, 4:00 PM
40.95
+0.23 (0.56%)
After-hours: Dec 20, 2024, 7:32 PM EST
CRISPR Therapeutics AG Market Cap
CRISPR Therapeutics AG has a market cap or net worth of $3.48 billion as of December 20, 2024. Its market cap has decreased by -37.68% in one year.
Market Cap
3.48B
Enterprise Value
1.77B
1-Year Change
-37.68%
Ranking
Category
Stock Price
$40.72
Market Cap Chart
Since October 19, 2016, CRISPR Therapeutics AG's market cap has increased from $560.10M to $3.48B, an increase of 520.53%. That is a compound annual growth rate of 25.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 3.48B | -30.10% |
| Dec 29, 2023 | 4.97B | 56.24% |
| Dec 30, 2022 | 3.18B | -45.12% |
| Dec 31, 2021 | 5.80B | -46.39% |
| Dec 31, 2020 | 10.82B | 221.74% |
| Dec 31, 2019 | 3.36B | 126.76% |
| Dec 31, 2018 | 1.48B | 53.95% |
| Dec 29, 2017 | 963.10M | 19.42% |
| Dec 30, 2016 | 806.50M | 43.99% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alvotech | 3.65B |
| Acadia Healthcare Company | 3.58B |
| Biohaven | 3.57B |
| Perrigo Company | 3.51B |
| PTC Therapeutics | 3.49B |
| Rhythm Pharmaceuticals | 3.41B |
| Verona Pharma | 3.37B |
| Oscar Health | 3.33B |